Work with your personal adviser to grow your wealth
Jeremy Sullivan

Upcoming Investor Presentation - 20th October 2016 - Ryman - EBOS - Metlifecare

HHG is proud to be hosting Chief Executives, Chief Financial Officers and Management from some of New Zealand's largest listed companies. Ryman Healthcare, EBOS Group and Metlifecare. The Investor Presentation which is to be held on the 20th of October 2016 at 9:30am through to 11:00am, at the newly built function centre of the Sudima Hotel, Christchurch Airport, followed by refreshments. If you would like to attend please RSVP by Thursday the 13th October at the latest. Seats are limited and...

Brexit - Should they stay or should they go?

On the 23rd of June 2016, Britain will vote on whether to stay within the European Union (EU). What does it all mean? What does it mean for Europe, the UK and the World? What does it mean for your portfolio? Firstly, what is “Brexit”? What is it? Brexit is an abbreviation of "British exit" that mirrors the term Grexit. It refers to the possibility that Britain will withdraw from the European Union. The country will hold an in-out referendum...

Will New Zealand's central bank cut rates further?

Jeremy Sullivan talks to CNBC Asia regarding the NZX, interest rates and the outlook for 2016 Click here to view the video

Pacific Edge - Internationalising the Entrepreneurial Firm

Pacific Edge Ltd is a NZX listed [PEB.NZX], New Zealand based biotechnology firm, specialising in the field of bladder cancer detection, through their primary product suite called ‘CX-Bladder’. The technology has been derived from the University of Otago and was established in 2001. The primary competitive advantage of the CX-Bladder product suite; is the non-invasive (urine) testing and their market leading diagnostic accuracy, compared to other urine based testing. The incumbent diagnostic tool is cystoscopy, which involves having a narrow tube...

Market Talk with Jeremy Sullivan. NBR Radio 19-02-2016

Jeremy Sullivan of Hamilton Hindin Greene and NBR's Duncan Bridgeman discuss this week's share market news ANZ Bank [NZX: ANZ] this week flagged global credit risk as a headwind for the banking sector, warning wholesale funding costs will probably increase. However, there are other forces at play buffeting banking stocks. Jeremy Sullivan, an analyst at Hamilton Hindin Greene, told NBR Radio’s Andrew Patterson he believes increasing regulation from across the Tasman is driving much of the negativity among investors. “Essentially, as...
Filed under Jeremy Sullivan \ NBR

Market Talk with Jeremy Sullivan. NBR Radio 18-01-2016

Click on the link to hear the NBR radio interview. 3m34s The New Zealand share market retreated again today, following intense volatility on Wall Street and other markets last week, cheap oil and scepticism over the Chinese economy. But the sell-off of local shares was less severe than anticipated perhaps, after last week’s global turmoil. The S&P/NZX 50 index was down nearly 2% this morning at 6055 – the lowest level since December 16. However, by 3pm the index had...
Filed under Jeremy Sullivan \ NBR

The Health & Safety Reform Bill & the affect on businesses in New Zealand

Introduction The Health and Safety Reform Bill (The Bill) is expected to come into power in the second half of this year (2015). The Bill is a result of the Pike River disaster (2010) and is the “biggest change to health and safety in 20 years” Hon. Simon Bridges (MP). Mr Bridges claims in his press release “Good health and safety is good for business. It is an investment in improved productivity.” In this essay I will critically analyse the topic...
Page 1 3
Find An Adviser CONTACT NOW
Become A Client START NOW